ABC DLBCL |
Activated B cell-like Diffuse large B-cell lymphoma |
BCR |
B-cell receptor |
BET |
Bromodomain and extra-terminal |
BTK |
Burton tyrosine kinase |
β-TrCP |
Beta-transducing repeat-containing protein |
CAC |
Colitis-associated carcinoma |
CAF |
Cancer-associated fibroblast |
CLL |
Chronic lymphomatic leukemia |
CNV |
Choroid neovascularization |
COPD |
Chronic obstructive pulmonary disease |
CSN5 |
COP9 signalosome 5 |
CTL |
Cytotoxic T-lymphocyte |
DC |
Dendritic cell |
DEN |
Diethylnitrosoamine |
DMF |
Dimethyl fumarate |
DSB |
Double-strand break |
EGFR |
Epidermal growth factor receptor |
HCC |
Hepatocellular carcinoma |
HNSCC |
Head and neck squamous cell carcinoma |
ICD |
Immunogenic cell death |
IKK |
IκB kinase |
IL-1 |
Interleukin-1 |
iNUB |
Inhibitor of NEMO-Ubiquitin binding |
IκB |
Inhibitor of kappa B |
KD |
Kinase domain |
KRAS |
Kirsten rat sarcoma viral oncogene homolog |
LPS |
Lipopolysaccharide |
LUBAC |
Linear ubiquitin chain assembly complex |
MALT |
Mucosa-associated lymphoid tissue |
MCL |
Mantle cell lymphoma |
MM |
Multiple myeloma |
mTORC |
Mammalian target of rapamycin complex |
NBD |
NEMO-binding domain |
NF-κB |
nuclear factor- “kappa-light-chain-enhancer” of activated B-cells |
NSCLC |
Non-small-cell lung carcinoma |
OV |
Oncolytic virus |
PD/PDL |
Programmed death/PD-ligand 1 |
POC |
Proof-of-concept |
RA |
Rheumatoid arthritis |
RHD |
Rel homology domain |
SCF |
S phase kinase-associated protein 1 (SKP1)-cullin 1-F-box protein |
SCID |
Severe combined immunodeficient |
SDD |
Scaffold/dimerization domain |
SH2 |
Src Homology 2 |
TAM |
Tumour-associated macrophage |
TCR |
T-cell receptor |
TLR |
Toll-like receptor |
TME |
Tumour microenvironment |
TNFα |
Tumor necrosis factor-alpha |
Treg |
Regulatory T cells |
UBC |
Ubiquitin-conjugating enzyme |
ULD |
Ubiquitin-like domain |